Apellis Pharmaceuticals (APLS) Q3 2026 Earnings

30JulConfirmed
Q4 2025
Q1 2026
Q1 2026
Next
-0.47
0.24
0.96
1.67

Details

Expected EPS
-0.311646
Actual EPS
N/A
Surprise EPS
0.31
Surprise Percent
+100%

Description

Apellis Pharmaceuticals (APLS) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts